These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 30351372)
21. Annual report of the Australian Meningococcal Surveillance Programme, 2007. Tapsall J; Commun Dis Intell Q Rep; 2008 Sep; 32(3):299-307. PubMed ID: 19062765 [TBL] [Abstract][Full Text] [Related]
22. Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature review. Pardo de Santayana C; Tin Tin Htar M; Findlow J; Balmer P Epidemiol Infect; 2023 Mar; 151():e57. PubMed ID: 37052295 [TBL] [Abstract][Full Text] [Related]
23. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex. Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933 [TBL] [Abstract][Full Text] [Related]
25. National surveillance for meningococcal disease in Japan, 1999-2014. Fukusumi M; Kamiya H; Takahashi H; Kanai M; Hachisu Y; Saitoh T; Ohnishi M; Oishi K; Sunagawa T Vaccine; 2016 Jul; 34(34):4068-71. PubMed ID: 27291085 [TBL] [Abstract][Full Text] [Related]
26. First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia. Marshall HS; Lally N; Flood L; Phillips P Med J Aust; 2020 Feb; 212(2):89-93. PubMed ID: 31909501 [TBL] [Abstract][Full Text] [Related]
27. Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France. Hong E; Barret AS; Terrade A; Denizon M; Antona D; Aouiti-Trabelsi M; Deghmane AE; Parent du Châtelet I; Levy-Bruhl D; Taha MK J Infect; 2018 Feb; 76(2):149-158. PubMed ID: 29132919 [TBL] [Abstract][Full Text] [Related]
28. Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017. Krone M; Gray S; Abad R; Skoczyńska A; Stefanelli P; van der Ende A; Tzanakaki G; Mölling P; João Simões M; Křížová P; Emonet S; Caugant DA; Toropainen M; Vazquez J; Waśko I; Knol MJ; Jacobsson S; Rodrigues Bettencourt C; Musilek M; Born R; Vogel U; Borrow R Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968827 [TBL] [Abstract][Full Text] [Related]
29. Relationships Between Clinico-Epidemiological Patterns of Invasive Meningococcal Infections and Complement Deficiencies in French South Pacific Islands (New Caledonia). Daures M; John M; Balter CV; Simon O; Barguil Y; Missotte I; Grangeon JP; Laumond-Barny S; Noel M; Besson-Leaud L; Spasic PE; de Suremain A; Gourinat AC; Descloux E J Clin Immunol; 2015 Jan; 35(1):47-55. PubMed ID: 25352052 [TBL] [Abstract][Full Text] [Related]
30. Clinical manifestations of invasive meningococcal disease in Victoria with the emergence of serogroup W and serogroup Y Neisseria meningitidis. Birrell MT; Strachan J; Holmes NE; Stevens K; Howden BP; Franklin LJ; Ivan M; Kwong JC Intern Med J; 2021 Mar; 51(3):390-397. PubMed ID: 32043702 [TBL] [Abstract][Full Text] [Related]
31. Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile. Villena R; Valenzuela MT; Bastías M; Santolaya ME Vaccine; 2019 Oct; 37(46):6915-6921. PubMed ID: 31585728 [TBL] [Abstract][Full Text] [Related]
32. Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination. Archer BN; Chiu CK; Jayasinghe SH; Richmond PC; McVernon J; Lahra MM; Andrews RM; McIntyre PB; Med J Aust; 2017 Nov; 207(9):382-387. PubMed ID: 29092704 [TBL] [Abstract][Full Text] [Related]
33. Analysis of epidemiological and molecular data from invasive meningococcal disease surveillance in the Czech Republic, 1993-2020. Křížová P; Honskus M; Okonji Z; Musílek M; Kozáková J Epidemiol Mikrobiol Imunol; 2022; 71(3):148-160. PubMed ID: 36257794 [TBL] [Abstract][Full Text] [Related]
34. A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa. Taha MK; Presa J; Serra L Int J Infect Dis; 2021 Mar; 104():189-197. PubMed ID: 33227521 [TBL] [Abstract][Full Text] [Related]
35. Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017. Nuttens C; Findlow J; Balmer P; Swerdlow DL; Tin Tin Htar M Euro Surveill; 2022 Jan; 27(3):. PubMed ID: 35057902 [TBL] [Abstract][Full Text] [Related]
36. Annual report of the Australian Meningococcal Surveillance Programme, 2008. ; Tapsall J Commun Dis Intell Q Rep; 2009 Sep; 33(3):259-67. PubMed ID: 20047198 [TBL] [Abstract][Full Text] [Related]
37. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines. Stein-Zamir C; Shoob H; Abramson N; Block C; Keller N; Jaffe J; Valinsky L Hum Vaccin Immunother; 2019; 15(1):242-248. PubMed ID: 30156954 [TBL] [Abstract][Full Text] [Related]
38. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. von Gottberg A; du Plessis M; Cohen C; Prentice E; Schrag S; de Gouveia L; Coulson G; de Jong G; Klugman K; Clin Infect Dis; 2008 Feb; 46(3):377-86. PubMed ID: 18181736 [TBL] [Abstract][Full Text] [Related]
39. Epidemiology of invasive meningococcal disease in France in 2003. Perrocheau A; Taha MK; Levy-Bruhl D Euro Surveill; 2005 Dec; 10(12):238-41. PubMed ID: 16371693 [TBL] [Abstract][Full Text] [Related]
40. Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis. Presa JV; de Almeida RS; Spinardi JR; Cane A Int J Infect Dis; 2019 Mar; 80():137-146. PubMed ID: 30641200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]